Global Platelet Rich Plasma Market indicating Industry Size, Demand, Trends and Forecast till 2022

Recently, a novel report developed using proven research methodologies at the headquarters of Fact. MR has identified various prominent factors and trends prompting market growth of platelet rich plasma market. The study is titled as “Platelet Rich Plasma Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022”, which deeply analyses the global market trends, with historical data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) during the mentioned forecast of 2017-2022. For the benefit of the readers, the report concludes with a special focus on the detailed profiles of the major vendors in the global platelet rich plasma market.

Request for Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=170

Platelet-rich plasma is a type of blood plasma product in which the concentration of platelets is much higher, more than four to eight times higher than the normal concentration of blood platelets. Platelet-rich plasma is also known as platelet enriched plasma, platelet-rich gel and platelet enriched gels. It is used in the quick and effective treatment of many medical conditions such as orthopedic diseases, neurological diseases, sports injuries and cardiothoracic diseases. Additionally, platelet-rich plasma has vast applications in the field of cosmetic surgery. This Fact.MR report on the global platelet-rich plasma market forecasts that the global platelet-rich plasma market will touch a value of nearly US$ 391 Mn in the year 2022 and grow at a robust CAGR during the assessment period, 2017-2022.

3 Forecast Highlights on Global Platelet-rich Plasma Market

1. As per the forecast of Fact.MR, the pure platelet-rich plasma kits segment is slated to touch a value of nearly US$ 90 Mn in the year 2022. This represents a robust CAGR growth during the assessment period of 2017-2022. The pure platelet-rich plasma kits segment is estimated to account for more than one-fourth of the revenue share of the product type segment by the year 2017 end and is expected to lose market share by the year 2022-end.

2. As per the forecast of Fact.MR, the dermatology clinics segment will reach a value of nearly US$ 58 Mn in the year 2017. This represents a robust CAGR growth during the forecast period. The dermatology clinics segment is estimated to account for nearly one-fourth of the revenue share of the end user segment in the year 2017 end, and is expected to gain market share by the end of the year 2022.

3. As per the forecast of Fact.MR, the orthopedic surgery segment is slated to reach a value of nearly US$ 151 Mn in 2022. The orthopedic surgery segment is expected to gain some market value by the end of the year 2022. The largest share is contributed by the North America region in the orthopedic surgery segment.

Browse Full Report with TOC- https://www.factmr.com/report/170/platelet-rich-plasma-market

PRP Therapy Instruments Poised to Touch Nearly US$ 86 Mn Value by 2022-end

As per the forecast of Fact.MR, the instruments segment is expected to reach a value of nearly US$ 86 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Instruments segment is expected to account for more than one-fourth of the revenue share of the global market by the year 2017, but, is also expected to lose market share by the end of the year 2022.

Hospitals – Key End-users of Platelet-rich Plasma

As per the forecast of Fact.MR, the hospitals end user segment is slated to touch a figure of nearly US$ 184 Mn in the year 2022. This represents a CAGR of 10.0% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospitals end user segment is expected to account for nearly half of the revenue share of the end user segment by the year 2017.

North America Set to Dominate Global Platelet-rich Plasma Market

The market in North America is set to dominate the global platelet-rich plasma market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America’s platelet-rich plasma market is expected to remain the most attractive region, growing at a robust CAGR over the assessment period.

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global platelet-rich plasma market through 2022, which include Arthrex, Inc., Johnson & Johnson, Zimmer Biomet Holdings, Inc., Exactech, Inc., Stryker Corporation, Terumo Medical Corporation, Biotest Aktiengesellschaft and CSL Limited.

Request Methodology of the Report- https://www.factmr.com/connectus/sample?flag=RM&rep_id=170

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized Healthcare market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us on Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.